Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1985-02-08
1991-06-11
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514392, 514649, A61K 3702, C07K 706
Patent
active
050232347
ABSTRACT:
A method of treatment of breast cancer in susceptible male animals whose testicular hormonal secretions are blocked by surgical or chemical means, e.g., by use of an LH-RH agonist, e.g., [D-Trp.sup.6, des-Gly-NH.sub.2.sup.10 ]LH-RH ethylamide which comprises administering an antiandrogen, e.g., flutamide and optionally at least one inhibitor of sex steroid biosynthesis, e.g., aminoglutethimide and/or ketoconazole. Pharmaceutical compositions useful for such treatment are also disclosed.
REFERENCES:
Chem. Abstr., vol. 102, (1985) 198133.
Chem. Abstr., vol. 101, (1984) 33528.
Chem. Abstr., vol. 85, (1976) 57322.
Chem. Abstr., vol. 100, (1984) 203971.
Chem. Abstr., vol. 96, (1982) 1121.
Chem. Abstr., vol. 102, (1985) 106663.
Chem. Abstr., vol. 100, (1984) 151639
Chem. Abstr., vol. 100, 185795 (1984).
Chem. Abstr., vol. 95, (1981) 773.
Chem. Abstr., vol. 100, (1984) 17879.
Chem. Abstr., vol. 98, (1983) 173536.
Chem. Abstr., vol. 86, (1977) 84114.
Santen, R. et al., "Decreased LH BIO/Immuno Ratio During Treatment with the Superagonist Analog of GnRH, Leuprolide, for Prostate Carcinoma" in Abstracts of the 7th International Congress of Endocrinology, Jul. 1-7, 1984, Ab #2254, p. 138.
R. J. Donnelly, "Continuous Subcutaneous Administration of `Zoladex` (ICI 118,630 an LH-RH Analogue) to Patients with Advanced Prostatic Cancer" in the Journal of Steroid Biochemistry, vol. 20 (#6B), Jun. 1984, p. 1375.
LandOfFree
Combination male breast cancer therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination male breast cancer therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination male breast cancer therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-782625